Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06381674 · ClinicalTrials.gov registry record · NA

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

A NA study of Rehabilitation and Mild Traumatic Brain Injury, Concussion, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT06381674: Recruiting NA study of Rehabilitation and Mild Traumatic Brain Injury, Concussion, sponsored by Oregon Health and Science University.

NCT06381674 is a NA study of Rehabilitation and Mild Traumatic Brain Injury, Concussion that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 100 participants, below the 159-participant average among 15 other Rehabilitation trials with a reported enrollment target (37% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06381674, a NA study of Rehabilitation and Mild Traumatic Brain Injury, Concussion, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

Current clinical assessment tools are often not sensitive enough to detect and treat some subtle (yet troubling) problems after mTBI. In this study, the investigators will use wearable sensors to both assess and treat people with mTBI. Specifically, the investigators will provide immediate feedback, with visual and/or auditory, on movement quality during physical therapy. This immediate feedback on performance may improve outcomes as the investigators will measure multiple body segments including head movements simultaneously with balance and walking exercises. Such complex movements are needed for safe return to high level activity and military duty. The investigators will test this approach against a standard vestibular rehabilitation program. There are few potential risks to this study such as increasing symptoms and a small fall risk. Benefits include physical therapy for balance problems regardless of therapy with or without biofeedback. An indirect benefit is to have data on correct dosage of physical therapy. The investigators will also distinguish which concussion subtype profiles benefit most from physical therapy. This will help healthcare providers and patients by providing more information to help establish clinical guidelines and new tools for physical therapy.

Primary Outcome

This single questionnaire will ask the participant to rate how they perceive their health has changed over the course of treatment. This scale is 1-7 where 1 is no change in quality of life and 7 is a great change that has made all the difference.

Interventions

  • OTHER Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback
  • OTHER Vestibular therapy for mTBI

Study Locations (3)

Oregon

  • Oregon Health & Science University - Portland

Texas

  • Fort Sam Houston - San Antonio

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-06-13
Est. Completion 2028-09-30
Phase NA

What NCT06381674 shows while recruiting

NCT06381674 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 159-participant average among 15 other Rehabilitation trials with a reported enrollment target (37% lower).

The record links to 3 conditions, with Rehabilitation appearing as the primary indexed condition, and to 2 interventions - of which Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback is the first listed.

NCT06381674 reports a single indexed study location in Oregon, Texas, Utah.

Frequently Asked Questions

What is clinical trial NCT06381674 about?

NCT06381674 is a clinical study titled "Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation". Current clinical assessment tools are often not sensitive enough to detect and treat some subtle (yet troubling) problems after mTBI. In this study, the investigators will use wearable sensors to both assess and treat people with mTBI. Specifically, the investigators will provide immediate feedback,...

What is the current status of trial NCT06381674?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-06-13. Estimated completion is 2028-09-30.

What conditions does trial NCT06381674 study?

This clinical trial studies the following conditions: Rehabilitation, Mild Traumatic Brain Injury, Concussion, Balance Impairment.

What interventions are being tested in trial NCT06381674?

The interventions under investigation include: Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback (OTHER), Vestibular therapy for mTBI (OTHER).

Who is sponsoring clinical trial NCT06381674?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06381674 being conducted?

This trial has 3 study locations across Oregon, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rehabilitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06381674's enrollment target sits among peer trials

100 6th of 15 higher than 10 of 15 other Rehabilitation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rehabilitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06381674, the US trial registry maintained by the National Library of Medicine. NCT06381674 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.